A "Good" Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use.

Front Psychiatry

Aix Marseille University, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.

Published: March 2022

AI Article Synopsis

  • Cannabis use is common in France but remains illegal, while CBD products are legally available; a study aimed to explore how CBD is used to reduce cannabis consumption.
  • Among surveyed users, 11% reported primarily using CBD for this purpose, with factors like tobacco and alcohol use being associated with this motive.
  • Successful cannabis reduction was linked to non-daily cannabis use and daily CBD use, with users citing reduced withdrawal symptoms as a key reason for their decreased cannabis consumption.

Article Abstract

Background: Although cannabis use is common in France, it is still criminalized. Cannabidiol (CBD) products, including CBD-rich cannabis, are legally available. Although previous results suggested that CBD may have benefits for people with cannabis use disorder, there is a lack of data on cannabis users who use CBD to reduce their cannabis consumption. We aimed to identify (i) correlates of this motive, and (ii) factors associated with successful attempts to reduce cannabis use.

Methods: A cross-sectional online survey among French-speaking CBD and cannabis users was conducted. Logistic regressions were performed to identify correlates of using CBD to reduce cannabis consumption and correlates of reporting a large reduction.

Results: Eleven percent ( = 105) of our study sample reported they primarily used CBD to reduce cannabis consumption. Associated factors included smoking tobacco cigarettes (adjusted odds ratio (aOR) [95% confidence interval (CI)] 2.17 [1.3-3.62], = 0.003) and drinking alcohol (aOR [95%CI] 1.8 [1.02-3.18], = 0.042). Of these 105, 83% used CBD-rich cannabis to smoke, and 58.7% reported a large reduction in cannabis consumption. This large reduction was associated with non-daily cannabis use (aOR [95%CI] 7.14 [2.4-20.0], < 0.001) and daily CBD use (aOR [95%CI] 5.87 [2.09-16.47], = 0.001). A reduction in cannabis withdrawal symptoms thanks to CBD use was the most-cited effect at play in self-observed cannabis reduction.

Conclusions: Cannabis use reduction is a reported motive for CBD use-especially CBD-rich cannabis to smoke-in France. More studies are needed to explore practices associated with this motive and to accurately assess CBD effectiveness.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968154PMC
http://dx.doi.org/10.3389/fpsyt.2022.829944DOI Listing

Publication Analysis

Top Keywords

reduce cannabis
20
cannabis
17
cannabis consumption
16
cbd-rich cannabis
12
cbd reduce
12
aor [95%ci]
12
cbd
10
cannabis users
8
identify correlates
8
large reduction
8

Similar Publications

Evidence on the effectiveness and implementation of mental health and psychosocial support (MHPSS) interventions for men in humanitarian settings is limited. Moreover, engagement and retention of men in such interventions has been challenging. Adaptations may therefore be required to improve the appropriateness and acceptability of these interventions for men.

View Article and Find Full Text PDF

Background: Cumulative risk scores predict negative outcomes including antisocial behaviour and mental health. Less work has examined the role of cumulative protection, despite the availability of preventive interventions focused on bolstering protection across domains. Understanding links between cumulative risk and protection measured in childhood and later outcomes can help to guide the timing of prevention programmes.

View Article and Find Full Text PDF

Empirical data on the effect of plant density (PD) and length of the vegetative phase (DVP) on plant growth, yield, and cannabinoid concentration of medicinal cannabis (Cannabis sativa L.) are still scarce, leading to a lack of specific cultivation recommendations. We conducted two greenhouse experiments to investigate the effect of PD in the range of 12-36 plants m-2 (D-trial) and DVP in the range of 1-4 weeks (V-trial) on plant morphology, biomass growth of individual plant organs, and CBD concentration of individual inflorescence fractions.

View Article and Find Full Text PDF

Synergistic Pain-Reducing Effects of (Chronic and Chronic In) and Cannabidiol-Rich Extracts in Experimental Pain Models.

Pharmaceuticals (Basel)

December 2024

Laboratório de Pesquisa em Fármacos, Curso de Farmácia, Departamento de Ciências Biológicas e da Saúde, Universidade Federal do Amapá, Rod. Josmar Chaves Pinto, km 02-Jardim Marco Zero, Macapá-AP, Macapá 68903-419, AP, Brazil.

The present study aimed to evaluate the potential synergy between pharmaceutical formulations containing L. (granulated-CHR OR and injectable nanodispersion-CHR IN) in conjunction with a cannabidiol (CBD)-rich extract of L. (CSE) on experimental pain models in Wistar rats.

View Article and Find Full Text PDF

Protective Action of Cannabidiol on Tiamulin Toxicity in Humans-In Vitro Study.

Int J Mol Sci

December 2024

Department of Preclinical Sciences and Infectious Diseases, Faculty of Veterinary Medicine and Animal Sciences, Poznan University of Life Sciences, 60-637 Poznan, Poland.

The growing awareness and need to protect public health, including food safety, require a thorough study of the mechanism of action of veterinary drugs in consumers to reduce their negative impact on humans. Inappropriate use of veterinary drugs in animal husbandry, such as tiamulin, leads to the appearance of residues in edible animal tissues. The use of natural substances of plant origin, extracted from hemp ( L.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!